AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24214919 — intervention group
Group type: EXPERIMENTAL
Intervention: [(15)O]H2O PET
Number of subjects: 31
Study 24214919 — intervention group
Group type: EXPERIMENTAL
Intervention: ASL MRI
Number of subjects: 31
Study 22425913 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/gemcitabine with eicosanoid modulators (celecoxib, zileuton, or both)
Number of subjects: 88
Study 19173165 — intervention group
Group type: COMPARATOR
Intervention: PDT alone (Group A)
Number of subjects: 92
Study 19173165 — intervention group
Group type: EXPERIMENTAL
Intervention: IVTA on the same day 1 hour after PDT (Group B)
Number of subjects: 92
Study 19173165 — intervention group
Group type: EXPERIMENTAL
Intervention: IVTA 1 week before PDT (Group C)
Number of subjects: 92
Study 19173165 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Groups B and C)
Number of subjects: 92
Study 19173165 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 92
Study 17497463 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-dextran
Number of subjects: 60
Study 17497463 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-sucrose
Number of subjects: 60
Study 15956899 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 42
Study 15956899 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 42
Study 12192358 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop attendees
Number of subjects: 37
Study 12192358 — intervention group
Group type: COMPARATOR
Intervention: Control reviewers
Number of subjects: 37
Study 10690067 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 24
Study 7594128 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.58 g/kg per day)
Number of subjects: 840
Study 7594128 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-protein diet (0.28 g/kg per day) with ketoacid-amino acid supplement (0.28 g/kg per day)
Number of subjects: 840
Study 7594128 — intervention group
Group type: COMPARATOR
Intervention: Usual-protein diet (1.30 g/kg per day)
Number of subjects: 840
Study 7594128 — intervention group
Group type: COMPARATOR
Intervention: Usual blood pressure level
Number of subjects: 840
Study 7594128 — intervention group
Group type: EXPERIMENTAL
Intervention: Low blood pressure level
Number of subjects: 840
Study 1789606 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid (Surgam)
Number of subjects: 139
Study 1789606 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 139
Study 1789606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 7031186 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA), 36 g/day
Number of subjects: 151
Study 7031186 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic acid (TEA), 6 g/day
Number of subjects: 151
Study 31249637 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonclosure of the peritoneum
Number of subjects: 112
Study 31249637 — intervention group
Group type: COMPARATOR
Intervention: Closure of the peritoneum
Number of subjects: 112
Study 29152243 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE) capsules for 8 weeks
Number of subjects: 55
Study 29152243 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 8 weeks
Number of subjects: 55
Study 26099205 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Manipulation (CTM) with lifestyle advice
Number of subjects: 50
Study 26099205 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle advice alone
Number of subjects: 50
Study 25799722 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolit super (4 capsules daily for 2 months)
Number of subjects: 57
Study 25799722 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 2 months)
Number of subjects: 57
Study 21599709 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking questions to confirm traits of in-group members
Number of subjects: 0
Study 21599709 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking questions to confirm traits of out-group members
Number of subjects: 0
Study 21599709 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for negative in-group traits
Number of subjects: 0
Study 21599709 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for positive out-group traits
Number of subjects: 0
Study 21599709 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderation effect of in-group identification
Number of subjects: 0
Study 19042161 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (24 mg/day)
Number of subjects: 407
Study 19042161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407
Study 19042161 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 407
Study 17313511 — intervention group
Group type: EXPERIMENTAL
Intervention: Lambdacyhalothrin-treated hammock nets (ITHN)
Number of subjects: 924
Study 17313511 — intervention group
Group type: COMPARATOR
Intervention: Placebo-treated hammock nets (PTHN)
Number of subjects: 924
Study 15020161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile shunt malfunction group
Number of subjects: 0
Study 15020161 — intervention group
Group type: COMPARATOR
Intervention: Functioning shunting systems
Number of subjects: 0
Study 12269648 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide aqueous nasal spray, 128 microg once daily
Number of subjects: 202
Study 12269648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 9437339 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow, unbuffered (SU)
Number of subjects: 42
Study 9437339 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow, buffered (SB)
Number of subjects: 42
Study 9437339 — intervention group
Group type: COMPARATOR
Intervention: Rapid, buffered (RB)
Number of subjects: 42
Study 9437339 — intervention group
Group type: COMPARATOR
Intervention: Rapid, unbuffered (RU)
Number of subjects: 42
Study 7814168 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifusal
Number of subjects: 276
Study 7814168 — intervention group
Group type: COMPARATOR
Intervention: Control (medically treated unstable angina)
Number of subjects: 276
Study 2653555 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine hydrochloride 50 mg bd (Kontexin)
Number of subjects: 9
Study 2653555 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin chloride 5 mg tid (Ditropan)
Number of subjects: 9
Study 2653555 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Phenylpropanolamine and Oxybutynin)
Number of subjects: 9
Study 2653555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 66471 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fibre diet
Number of subjects: 18
Study 66471 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 31743054 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy with temozolomide
Number of subjects: 186
Study 30957699 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric-motor device at 100% concentric speed (EX1)
Number of subjects: 40
Study 30957699 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric-motor device at 150% concentric speed (EX2)
Number of subjects: 40
Study 30957699 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional flywheel device (FW)
Number of subjects: 40
Study 30957699 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 40
Study 28069560 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention with access to weight gain tracker and diet and physical activity goal-setting tools.
Number of subjects: 1335
Study 28069560 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no access to weight gain tracker and goal-setting tools).
Number of subjects: 1335
Study 26054136 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60
Study 26054136 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 60
Study 24119227 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate sodium
Number of subjects: 14
Study 24119227 — intervention group
Group type: COMPARATOR
Intervention: Other immunosuppressive agents
Number of subjects: 14
Study 21208594 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAM intervention (depression care management intervention focusing on optimizing antidepressant therapy through patient education, symptom monitoring, adherence promotion, and side-effect management)
Number of subjects: 168
Study 21208594 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 168
Study 21208594 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAM intervention
Number of subjects: 168
Study 18952309 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation with neoadjuvant androgen deprivation
Number of subjects: 0
Study 18952309 — intervention group
Group type: COMPARATOR
Intervention: Radiation without neoadjuvant androgen deprivation
Number of subjects: 0
Study 17197656 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Re‐Entry Module (CRM)
Number of subjects: 103
Study 17197656 — intervention group
Group type: COMPARATOR
Intervention: Standard group psychoeducation
Number of subjects: 103
Study 14982509 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast plus cetirizine
Number of subjects: 60
Study 14982509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine only
Number of subjects: 60
Study 14982509 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast only
Number of subjects: 60
Study 14982509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10900108 — intervention group
Group type: EXPERIMENTAL
Intervention: CROM device for measuring abnormal head postures
Number of subjects: 39
Study 10900108 — intervention group
Group type: EXPERIMENTAL
Intervention: CROM device for assessing limitations of ductions
Number of subjects: 39
Study 10900108 — intervention group
Group type: EXPERIMENTAL
Intervention: CROM device for diplopia field testing
Number of subjects: 39
Study 10900108 — intervention group
Group type: EXPERIMENTAL
Intervention: CROM device for diplopia field testing at one third of a meter vs 6 m
Number of subjects: 39
Study 9286851 — intervention group
Group type: EXPERIMENTAL
Intervention: mibefradil 100 mg once daily
Number of subjects: 640
Study 9286851 — intervention group
Group type: COMPARATOR
Intervention: diltiazem CD 360 mg once daily
Number of subjects: 640
Study 9286851 — intervention group
Group type: COMPARATOR
Intervention: nifedipine SR 40 mg twice daily
Number of subjects: 640
Study 9286851 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 10 mg once daily
Number of subjects: 640
Study 9286851 — intervention group
Group type: COMPARATOR
Intervention: nifedipine GITS 60 mg once daily
Number of subjects: 640
Study 7870897 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of coffee consumption
Number of subjects: 9003
Study 7870897 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea consumption
Number of subjects: 9003
Study 7870897 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated overall caffeine consumption
Number of subjects: 9003
Study 7870897 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 9003
Study 3490807 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent electrical stimulation of the muscles of the legs (external electrodes), performed daily 2 X 30 min during the stimulation period (S)
Number of subjects: 10
Study 3490807 — intervention group
Group type: COMPARATOR
Intervention: Non-stimulation period (NS)
Number of subjects: 10
Study 3490807 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation period (S)
Number of subjects: 10
Study 29703724 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-led DSME program
Number of subjects: 222
Study 29703724 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW+PL
Number of subjects: 222
Study 29703724 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-only
Number of subjects: 222
Study 29703724 — intervention group
Group type: COMPARATOR
Intervention: EUC
Number of subjects: 222
Study 27261590 — intervention group
Group type: EXPERIMENTAL
Intervention: Haishengsu (HSS)
Number of subjects: 248
Study 27261590 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 248
Study 25136358 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobil Diab system (telemedical approach for diabetes management)
Number of subjects: 40
Study 25136358 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study 22287122 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subtotal thyroidectomy (BST)
Number of subjects: 200
Study 22287122 — intervention group
Group type: COMPARATOR
Intervention: Total thyroidectomy (TT)
Number of subjects: 200
Study 20723593 — intervention group
Group type: EXPERIMENTAL
Intervention: Liu wei di huang wan (LDW), 12 pills, 0.2 g/pill, twice daily for 14 days
Number of subjects: 12
Study 20723593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 20723593 — intervention group
Group type: EXPERIMENTAL
Intervention: Liu wei di huang wan (LDW)
Number of subjects: 12
Study 18684342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 80 microg
Number of subjects: 1015
Study 18684342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg
Number of subjects: 1015
Study 18684342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg
Number of subjects: 1015
Study 18684342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1015
Study 12486426 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril treatment for 6 weeks
Number of subjects: 19694
Study 9703036 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal lenses with a +1.50 D add in a flattop segment
Number of subjects: 82
Study 9703036 — intervention group
Group type: COMPARATOR
Intervention: Single-vision spectacle lenses
Number of subjects: 82
Study 8012860 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS) 4 mg
Number of subjects: 13
Study 8012860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2690558 — intervention group
Group type: EXPERIMENTAL
Intervention: Uppsala technique for internal fixation of femoral neck fractures
Number of subjects: 222
Study 2690558 — intervention group
Group type: COMPARATOR
Intervention: von Bahr technique for internal fixation of femoral neck fractures
Number of subjects: 222
Study 2690558 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without pain at 4 months
Number of subjects: 222
Study 2690558 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with pain at 4 months
Number of subjects: 222
Study 4904935 — intervention group
Group type: EXPERIMENTAL
Intervention: clofazimine (Lamprene)
Number of subjects: 24
Study 4904935 — intervention group
Group type: COMPARATOR
Intervention: prednisolone
Number of subjects: 24
Study 31738150 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal sterile water (0.5 ml)
Number of subjects: 94
Study 31738150 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (0.1 mg/kg plus 0.5 ml of intradermal sterile water)
Number of subjects: 94
Study 27921276 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib (oral MEK inhibitor)
Number of subjects: 118
Study 27921276 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 118
Study 27921276 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib
Number of subjects: 118
Study 26155923 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (Flovent HFA)
Number of subjects: 10
Study 26155923 — intervention group
Group type: COMPARATOR
Intervention: Short acting bronchodilators (Proventil HFA)
Number of subjects: 10
Study 26155923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both inhalers (ICS and bronchodilators)
Number of subjects: 10
Study 22712609 — intervention group
Group type: COMPARATOR
Intervention: MVI 100
Number of subjects: 374
Study 22712609 — intervention group
Group type: EXPERIMENTAL
Intervention: MVI 200
Number of subjects: 374
Study 22712609 — intervention group
Group type: EXPERIMENTAL
Intervention: MVI 150
Number of subjects: 374
Study 21830508 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress training during flight simulator skill acquisition
Number of subjects: 30
Study 21830508 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stress training)
Number of subjects: 30
Study 19808136 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 600-mg extended-release tablets at doses of 2400, 3600, 4800, or 6000 mg
Number of subjects: 32
Study 19808136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 17126771 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine consumption with a high-fat meal
Number of subjects: 0
Study 17126771 — intervention group
Group type: COMPARATOR
Intervention: High-fat meal without red wine
Number of subjects: 0
Study 15534239 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg daily)
Number of subjects: 69
Study 15534239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 11345514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive orientation to daily occupational performance (CO-OP)
Number of subjects: 0
Study 11345514 — intervention group
Group type: COMPARATOR
Intervention: Current therapeutic approach
Number of subjects: 0
Study 9013720 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with carbetamide and caffeine to induce autotetraploid cells
Number of subjects: 0
Study 9013720 — intervention group
Group type: EXPERIMENTAL
Intervention: Expected probabilities derived from computer simulation
Number of subjects: 0
Study 9013720 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of NOR-bearing chromosomes
Number of subjects: 0
Study 8352671 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain magnetic resonance imaging (MRI)
Number of subjects: 418
Study 3305185 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravariceal sclerotherapy
Number of subjects: 54
Study 3305185 — intervention group
Group type: COMPARATOR
Intervention: Paravariceal sclerotherapy
Number of subjects: 54
Study 30744491 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation-based motor imagery training (Tele-MIT) twice a week for 8 weeks
Number of subjects: 0
Study 30744491 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list group without any additional specific treatment)
Number of subjects: 0
Study 31535138 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 89
Study 31535138 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA supplementation
Number of subjects: 89
Study 31535138 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 89
Study 26057328 — intervention group
Group type: EXPERIMENTAL
Intervention: RGTA (Cacicol20) instilled once a day
Number of subjects: 18
Study 26057328 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (control group)
Number of subjects: 18
Study 23809977 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 0
Study 23809977 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 23809977 — intervention group
Group type: COMPARATOR
Intervention: Tacks
Number of subjects: 0
Study 23809977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21355143 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture applied to Baihui (GV 20), Yintang (EX-HN 3), Sishencong (EX-HN 1), Taichong (LR 3) and placebo orally.
Number of subjects: 43
Study 21355143 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture applied to non-acupoint spots with shallow needling technique and Fluoxetine taken orally.
Number of subjects: 43
Study 21355143 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (Acupuncture)
Number of subjects: 43
Study 21355143 — intervention group
Group type: COMPARATOR
Intervention: Control group (Fluoxetine)
Number of subjects: 43
Study 19486853 — intervention group
Group type: EXPERIMENTAL
Intervention: Education/enhanced care
Number of subjects: 21
Study 19486853 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 21
Study 19486853 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 21
Study 19486853 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 21
Study 16750465 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine orotate (5 mg, doubled to 10 mg QD if SiDBP >= 90 mm Hg after 4 weeks)
Number of subjects: 109
Study 16750465 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine besylate (5 mg, doubled to 10 mg QD if SiDBP >= 90 mm Hg after 4 weeks)
Number of subjects: 109
Study 16750465 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine orotate
Number of subjects: 109
Study 16750465 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine besylate
Number of subjects: 109
Study 15477565 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronal cell transplantation
Number of subjects: 9
Study 15477565 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 9
Study 11323582 — intervention group
Group type: EXPERIMENTAL
Intervention: Band ligation and propranolol (propranolol group)
Number of subjects: 77
Study 11323582 — intervention group
Group type: COMPARATOR
Intervention: Band ligation alone (control group)
Number of subjects: 77
Study 9158883 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 mg kg‐1 dolasetron mesylate (1.8 mg kg‐1 dolasetron base) by intravenous administration
Number of subjects: 24
Study 9158883 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 mg kg‐1 dolasetron mesylate (1.8 mg kg‐1 dolasetron base) by oral administration
Number of subjects: 24
Study 9158883 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration
Number of subjects: 24
Study 9158883 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration
Number of subjects: 24
Study 9158883 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intravenous and oral administration
Number of subjects: 24